STOCK TITAN

iSpecimen® to Report Third Quarter 2021 Results on November 4, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

iSpecimen Inc. (NASDAQ: ISPC) will announce its third quarter financial results on November 4, 2021, before market open. The conference call is scheduled for 8:30 a.m. ET, featuring remarks from CEO Christopher Ianelli, CFO Tracy Curley, and COO Jill Mullan. Interested individuals can join the call via toll-free numbers or access a replay until November 18, 2021. The company provides an online marketplace for human biospecimens, connecting scientists with healthcare providers for medical research.

Positive
  • None.
Negative
  • None.

LEXINGTON, Mass., Oct. 21, 2021 /PRNewswire/ -- iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the third quarter ended September 30, 2021, before the market open on Thursday, November 4, 2021.

The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks by Christopher Ianelli, MD, PhD, CEO and President, Tracy Curley, CFO, and Jill Mullan, COO.

Event:

iSpecimen Third Quarter 2021 Results Conference Call

Date:

Thursday, November 4, 2021

Time:

8:30 a.m. Eastern Time

Live Call:

+1-855-327-6838 (Toll Free) or + 1-604-235-2082 (International)

Webcast:

https://themediaframe.com/mediaframe/webcast.html?webcastid=ReKRVin0

For interested individuals unable to join the conference call, a replay will be available through November 18, 2021, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 10016869. An archived version of the webcast will also be available on iSpecimen's Investor Relations site: https://ispecimen.irpass.com/.

About iSpecimen
iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. For more information about iSpecimen, please visit www.ispecimen.com.

Forward Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks factors contained in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements.

Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

For further information, please contact:

Investor Contact
KCSA Strategic Communications
Allison Soss / Scott Eckstein
iSpecimen@kcsa.com

Media Contact
Kaitlynn Cooney
For iSpecimen
iSpecimen@brodeur.com  
617.587.2811

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ispecimen-to-report-third-quarter-2021-results-on-november-4-2021-301405006.html

SOURCE iSpecimen Inc.

FAQ

When will iSpecimen report its third quarter 2021 financial results?

iSpecimen will report its third quarter 2021 financial results on November 4, 2021.

What time is the iSpecimen conference call scheduled for?

The iSpecimen conference call is scheduled for 8:30 a.m. Eastern Time on November 4, 2021.

Who will be speaking during the iSpecimen conference call?

The conference call will feature remarks by CEO Christopher Ianelli, CFO Tracy Curley, and COO Jill Mullan.

How can I access the iSpecimen conference call?

You can access the iSpecimen conference call by dialing +1-855-327-6838 for toll-free access or +1-604-235-2082 for international calls.

Is there a replay available for the iSpecimen conference call?

Yes, a replay of the iSpecimen conference call will be available until November 18, 2021.

iSpecimen Inc.

NASDAQ:ISPC

ISPC Rankings

ISPC Latest News

ISPC Stock Data

3.30M
823.02k
14.5%
4.04%
7.79%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States of America
WOBURN